Clinical Trial Update: Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial update for a meningococcal conjugate vaccine (MCV5) containing serogroups A, C, Y, W, and X in healthy adults; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MCV5 (Meningococcal Conjugate Vaccine Containing Serogroups A, C, Y, W, and X) (meningococcal conjugate vaccine)

Snippet

Sponsor: PATH | Conditions: Meningococcal Vaccines | Phase 1 | Status: COMPLETED | Results posted: 2021-03-30